Your clinician reviews your medical history, goals, and biomarkers to determine eligibility
Progress in retinal and eye research
Now there will be some variation because people come in with different risk acuities, different risk factors, which could make the surgery end up going much longer, which would therefore result in a different, more expensive price, which behooves us all to stay as healthy as we possibly can
However, the mechanisms underlying these effects have not been fully elucidated, with some preclinical studies revealing inconsistent results (20)
Given that insurance covered more than 95% of GLP-1 RA costs in our study, the high cost of GLP-1 RAs placed a substantial financial burden on health insurance plans
While studies are still evolving, the general consensus is to start with a lower dose and adjust as needed, under the guidance of a healthcare provider